EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells

Chang-Han Wu, Ching-Wen Huang, Yen-Cheng Chen, Kwan-Ling Yip, Zhi-Feng Miao, Wei-Chih Su, Tsung-Kun Chang, Hsiang-Lin Tsai, Yung-Sung Yeh, Hsiao-Sheng Liu, Jaw-Yuan Wang iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Chang-Han Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Glucose, Doxycycline. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance is a major contributor to treatment failure in most patients with cancer. Hyperglycaemia enhances chemoresistance in stage III colorectal cancer (CRC) patients, potentially through a mechanism involving c‐Myc. Phospho‐PGC‐1α (p‐PGC‐1α), a transcription coactivator, regulates energy metabolism with c‐Myc and is a key regulator of mitochondrial biogenesis. We hypothesised that high glucose (HG) promotes mitochondrial biogenesis by upregulating c‐Myc and p‐PGC‐1α, thus enhancing chemoresistance in CRC cells, and that inhibiting mitochondrial biogenesis alleviates this chemoresistance. In vitro, HG significantly increased mitochondrial mass ( p < 0.001), oxygen consumption rate ( p < 0.001), cell migration ( p < 0.05) and oxaliplatin resistance ( p < 0.001) in LoVo and HCT116 cells. p‐PGC‐1α and COX4 protein expression were increased in the HG and oxaliplatin‐resistance groups in LoVo and HCT116 cells (all p < 0.001) and decreased in the doxycycline group ( p < 0.001). In vivo, doxycycline combined with oxaliplatin more notably reduced tumour volume than oxaliplatin alone in hyperglycaemic BALB/c nude mice ( p < 0.05). c‐Myc, p‐PGC‐1α and COX4 protein expression were significantly higher in tissues with CRC and hyperglycaemia who experienced relapse than in those with CRC and normoglycaemia who did not experience relapse (all p < 0.05). Overall, this study demonstrated that HG upregulates p‐PGC‐1α and COX4 expression to enhance oxaliplatin resistance by promoting mitochondrial biogenesis and indicates that doxycycline can overcome the chemoresistance induced by HG. Repurposing of doxycycline might reduce chemoresistance in hyperglycaemic CRC patients receiving adjuvant chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmGlucoseDoxycyclineMitochondriaOrganelle BiogenesisDrug RepositioningHumansAnimalsMiceMice, NudeOxaliplatinPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaHCT116 CellsMice, Inbred BALB CXenograft Model Antitumor AssaysProto-Oncogene Proteins c-mycCell Line, TumorCell MovementGene Expression Regulation, NeoplasticMale

Stichwörter der Autor:innen

chemoresistancedoxycycline repurposehyperglycaemiamitochondrial biogenesisp‐PGC‐1α overexpression

Substanzen

GlucoseDoxycyclineOxaliplatinPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaProto-Oncogene Proteins c-mycPPARGC1A protein, human

Autor:innen und Institutionen

  • Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Surgery, Faculty of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Ganhshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Division of Trauma and Surgical Critical Care, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID-Profile: Jaw-Yuan Wang

Förderung

  • National Science and Technology Council

Zitieren

APA

Wu, C. H., Huang, C. W., Chen, Y. C., Yip, K. L., Miao, Z. F., Su, W. C., Chang, T. K., Tsai, H. L., Yeh, Y. S., Liu, H. S., & Wang, J. Y. (2025). Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70795

Vancouver

Wu CH, Huang CW, Chen YC, Yip KL, Miao ZF, Su WC, et al. Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70795

BibTeX
@article{Wu2025,
  author = {Wu, Chang-Han and Huang, Ching-Wen and Chen, Yen-Cheng and Yip, Kwan-Ling and Miao, Zhi-Feng and Su, Wei-Chih and Chang, Tsung-Kun and Tsai, Hsiang-Lin and Yeh, Yung-Sung and Liu, Hsiao-Sheng and Wang, Jaw-Yuan},
  title = {Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70795}
}
Kostenlos starten →